Update in Interstitial Lung Disease 2020
Am J Respir Crit Care Med
.
2021 Jun 1;203(11):1343-1352.
doi: 10.1164/rccm.202103-0559UP.
Authors
Anna J Podolanczuk
1
,
Alyson W Wong
2
3
,
Shigeki Saito
4
,
Joseph A Lasky
4
,
Christopher J Ryerson
2
3
,
Oliver Eickelberg
5
Affiliations
1
Division of Pulmonary and Critical Care, Department of Medicine, Weill Cornell Medical College, Cornell University, New York, New York.
2
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
3
Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.
4
Section of Pulmonary Disease, Critical Care and Environmental Medicine, Department of Medicine, Tulane University, New Orleans, Louisiana; and.
5
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
PMID:
33835899
PMCID:
PMC8759209
DOI:
10.1164/rccm.202103-0559UP
No abstract available
Publication types
Review
MeSH terms
Humans
Lung Diseases, Interstitial* / diagnosis
Lung Diseases, Interstitial* / etiology
Lung Diseases, Interstitial* / therapy
Grants and funding
K08 HL146979/HL/NHLBI NIH HHS/United States
K23 HL140199/HL/NHLBI NIH HHS/United States
R01 HL146519/HL/NHLBI NIH HHS/United States